Literature DB >> 35060338

Chemical profiling and quantification of multiple components in Jin-Gu-Lian capsule using a multivariate data processing approach based on UHPLC-Orbitrap Exploris 240 MS and UHPLC-MS/MS.

Zu-Ying Zhou1,2, Yong Huang1, Jin-Chao Xiao1,2, Hui Liu1,2, Yong-Lin Wang1, Zi-Peng Gong1, Yue-Ting Li1, Ai-Min Wang3, Yong-Jun Li1, Lin Zheng1.   

Abstract

The Jin-Gu-Lian capsule, a Chinese Miao herbal compound, is widely used to treat rheumatoid arthritis. In this study, a rapid, selective, and sensitive UHPLC-Orbitrap Exploris 240 MS method was developed to analyze the chemical composition of Jin-Gu-Lian capsules. A total of 88 compounds were identified, including 23 flavonoids, 23 organic acids, 14 phenylpropanoids, 12 phenols, eight alkaloids, four terpenes, three quinones, and one ketone. Among these, 21 compounds were clearly detected based on a comparison with reference standards and selected as quality control markers. Thereafter, these compounds were simultaneously determined in the Jin-Gu-Lian capsules. The established method was successfully validated and applied for the simultaneous determination of 21 biologically active compounds in Jin-Gu-Lian capsules of 27 sample batches. Quantitative data of the analytes were analyzed using multivariate statistical analysis to determine the quality of the Jin-Gu-Lian capsules. Four compounds (JGLC6 [salidroside], JGLC8 [chlorogenic acid], JGLC12 [liriodendrin], JGLC19 [quercetin]) were identified as chemical markers for quality control of Jin-Gu-Lian capsules. Altogether, the established method was validated as a novel and efficient tool, that can be used for rapid analysis of Jin-Gu-Lian capsules. Accordingly, this study serves as a reference for scientific research on traditional Chinese and ethnic medicine.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  Jin-Gu-Lian capsule; Orbitrap Exploris 240 mass spectrometry; chemical profiling; multivariate statistical analysis; quality control

Mesh:

Substances:

Year:  2022        PMID: 35060338     DOI: 10.1002/jssc.202100762

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  Pharmacokinetics Study of Jin-Gu-Lian Prescription and Its Core Drug Pair (Sargentodoxa cuneata (Oliv.) Rehd. et W and Alangium chinense (Lour.) Harms) by UPLC-MS/MS.

Authors:  Lin Zheng; Ting Zhou; Hui Liu; Zuying Zhou; Mingyan Chi; Yueting Li; Zipeng Gong; Yong Huang
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.